DIBIASE MARY (Chief Operating Officer) sold 0.6% of their position (857.00 shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $1.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2023ACC: 0001628280-23-023445
Officer· Chief Operating Officer
Since Sep 2021
-857.00
Net shares
Net seller
$1.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
857.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−857.00
Price / share
$1.93
Trade value
$1.65K
% of position
0.6%
6/23/2023
151.86K→151K
Total
Net shares
−857.00
Net value
-$1.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/23/2023 | S · Sale | −857.00 | $1.93 | $1.65K | 0.6% | 151.86K | 151K |
| Total | −857.00 | -$1.65K | ||||||
Derivative Transactions0
No derivative transactions reported